Medicine
Children and seniors to join Oxford’s coronavirus vaccine trial
Oxford University is enrolling people older than 70 and children between the ages of 5 and 12 in a Phase 2 coronavirus vaccine trial.
New HIV vaccine gives monkeys longer-lasting protection
Scientists have created an HIV vaccine that triggers two types of immune response, providing monkeys with longer-lasting protection from infection.
CBD slows growth of brain cancer cells in a Petri dish
The cannabis compound CBD can slow the growth of brain cancer cells, but it’s a long way from a new cancer treatment.
Researchers are rushing to freeze… lab mice sperm?
With their labs closing and the future unclear, researchers are sending precious cargo — the sperm of lab mice — to be frozen and stored.
A proposal to infect volunteers, the race to a vaccine, and more COVID-19 updates
In our weekly news roundup, we take you inside the fight against COVID-19 to explore the solutions on the frontlines of an unprecedented global response.
Using Ebola to fight brain cancer
A lab-altered Ebola virus can hunt human brain cancer cells without killing healthy cells.
Oxford coronavirus vaccine could be ready by September
Millions of doses of an Oxford coronavirus vaccine now in the human trial stage could be ready by September, according to researchers.
An “old school” COVID-19 vaccine appears to work in monkeys
An in-development COVID-19 vaccine has protected animals from catching the novel coronavirus for the first time, according to the team behind it.
Would you volunteer to be infected with COVID-19?
Coronavirus vaccine development could take months. There’s a potential shortcut though: purposefully exposing research subjects to the virus.
At-home test kits, new vaccine developments, and more COVID-19 updates
In our weekly news roundup, we take you inside the fight against COVID-19 to explore the solutions on the frontlines of an unprecedented global response.